ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,294.31
0.23%
Dow Jones
38,686.32
0.00%
Gold vs US Dollar
2,326.78
0.04%
Brent Oil
81.045
0.30%
Bitcoin
69,411.76
2.45%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. InflaRx NV (IFRX) Share Price

IFRX InflaRx NV

1.43
0.00 (0.00%)
Pre Market
Last Updated: 12:00:05
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 InflaRx NV NASDAQ:IFRX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 1.43 1.35 1.60 0.00 0.00   11:00:05   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 63k -42.67M -0.7884 -1.81 77.39M
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore IFRX News
21/05/202421:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
21/05/202419:30GLOBEInflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
08/05/202413:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/05/202412:30GLOBEInflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
30/04/202412:30GLOBEInflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
24/04/202412:30GLOBEInflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
21/03/202411:00GLOBEInflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans
Period
Draw mode
Data Downloads for IFRX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest InflaRx NV Articles